BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30681467)

  • 1. Vitamin D, Omega-3 Fatty Acids Don't Lower Rates of Cancer or CVD.
    Zolot J
    Am J Nurs; 2019 Feb; 119(2):15. PubMed ID: 30681467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
    Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
    Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE;
    Circ Res; 2020 Jan; 126(1):112-128. PubMed ID: 31895658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutrition 101: physicians can no longer ignore the healing power of diet and nutritional supplements.
    O'Keefe JH
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):593-6. PubMed ID: 18510475
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture.
    Donlon CM; LeBoff MS; Chou SH; Cook NR; Copeland T; Buring JE; Bubes V; Kotler G; Manson JE
    Contemp Clin Trials; 2018 Apr; 67():56-67. PubMed ID: 29408561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
    de Bree A; Mennen LI; Hercberg S; Galan P
    Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and Omega-3 Supplements for Preventing Cancer and Other Chronic Diseases.
    Manson J
    Oncology (Williston Park); 2019 Jan; 33(1):36-8. PubMed ID: 30731018
    [No Abstract]   [Full Text] [Related]  

  • 8. Research digest: vitamin D supplementation.
    Preiss D; Sattar N
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):91. PubMed ID: 30683222
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the Vitamin D and OmegA-3 trial (VITAL).
    Pradhan AD; Manson JE
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):252-6. PubMed ID: 25864623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with cardiovascular disease take fish oil?
    Nair GM; Connolly SJ
    CMAJ; 2008 Jan; 178(2):181-2. PubMed ID: 18195293
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
    Haidari F; Abiri B; Iravani M; Razavi SM; Sarbakhsh P; Ahmadi-Angali K; Vafa M
    Trials; 2019 Dec; 20(1):682. PubMed ID: 31815661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
    Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
    J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D: a cardioprotective agent?
    Liss Y; Frishman WH
    Cardiol Rev; 2012; 20(1):38-44. PubMed ID: 22143284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1823-4. PubMed ID: 16217295
    [No Abstract]   [Full Text] [Related]  

  • 17. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S
    Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and the heart: why we need large-scale clinical trials.
    Manson JE
    Cleve Clin J Med; 2010 Dec; 77(12):903-10. PubMed ID: 21147944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 Fatty Acids and Cardiovascular Disease Prevention.
    Tomdio A; Ritchie M; Miller AC
    Am Fam Physician; 2019 Aug; 100(4):209-210. PubMed ID: 31414778
    [No Abstract]   [Full Text] [Related]  

  • 20. Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials.
    Manson JE; Bassuk SS; Buring JE;
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105522. PubMed ID: 31733345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.